ot i peptide OT - Ot1 mice express the mouse alpha-chain and beta-chain T cell receptor The OT-I Peptide: A Cornerstone in Immunological Research

Ot1 mice The OT-I peptide has emerged as a crucial tool in immunology, primarily recognized for its role in studying T cell responses. This specific peptide antigen, derived from ovalbumin (OVA), plays a pivotal role in activating and manipulating CD8+ T cells in research settings. Understanding the intricacies of the OT-I peptide is fundamental for advancing our knowledge in areas ranging from vaccine development to cancer immunotherapy.CD8 + T-cell responses induced by the OT-I peptide, OVA ...

At its core, the OT-I peptide is a class I (Kb)-restricted peptide epitope of OVA, specifically the sequence SIINFEKL. This octameric peptide is presented by the MHC class I molecule, H-2Kb, a key component in the adaptive immune system's ability to recognize and eliminate infected or abnormal cells. The OT-I T cell receptor (TCR) is a transgenic TCR engineered to specifically recognize this ovalbumin-derived peptide (OVA) presented in the context of H-2Kb. This precise recognition makes the OT-I system an invaluable model for dissecting T cell-mediated immunity.

Researchers frequently utilize transgenic mouse models, such as OT-I mice, which express this specific TCR. These mice allow for the precise tracking and analysis of CD8+ T cells that are specific for the OT-I peptide.OVA peptide - MedchemExpress.com Studies involving heterozygous OT-I mice have revealed insights into how antigen-specific CD8+ T cells can shift their behavior and function. Furthermore, investigations into the spontaneous partial loss of the OT-I transgene have provided valuable information about genetic stability and its implications in research models, noting transgene loss in a small percentage of pups, with specific chains being affected作者：AR Abraham·2024—Purpose : Antigen specific T cell trafficking allows targeted delivery of immune modulating cell therapies into sites of ongoing immune dysregulation..

The OT-I peptide is widely used to stimulate T cells in PBMCs (Peripheral Blood Mononuclear Cells) and to quantify peptide epitope specificity and IFN-γ releasing effector cells using assays like ELISPOT. This application highlights the peptide's utility in both _in vitro_ and _in vivo_ studies. The activation of transgenic OT-I T cells has been shown to be triggered by various stimuli, including bacteria expressing OVA variants. This underscores the peptide's central role in understanding effector cell function and immune memory003831 - OT-1 Strain Details.

Beyond its direct recognition by the OT-I TCR, the concept of altered peptide ligands (APLs) has also been explored with the OT-I TCRDendritic cell preactivation impairs MHC class II .... Researchers have investigated how APLs, which are altered peptide sequences with single amino acid substitutions, can still interact with the OT-I TCR and influence T cell responses differently than the native peptide. This area of research is crucial for understanding T cell tolerance and the development of immunotherapies. For instance, T4/OVA, a conjugate of thyroxine T4 and ovalbumin, is an altered peptide that can be used to stimulate OT-I CD8+ T cells, demonstrating the nuanced ways T cell activation can be modulated.

The specificity of the OT-I TCR extends to its interaction with specific MHC molecules. It is a MHC class I-restricted receptor. In contrast, its counterpart, the OT-II TCR, which is designed to recognize an OVA-derived peptide presented by MHC class II molecules, is primarily associated with CD4+ T cells004194 - OT-II Strain Details. Studies comparing OT-I CD8+ T cells and OT-II T cells reveal distinct roles and activation mechanisms within the immune system. OT-II transgenic mice express the mouse alpha-chain and beta-chain T cell receptor that pairs with the CD4 co-receptor, making them ideal for studying CD4+ T cell responses.

The practical application of the OT-I peptide is evident in various research contexts. For example, cell lines that secrete OVA peptides, such as the EG7-OVA cell line, can be used to activate OT-I or OT-II cells _in vitro_. This facilitates the study of cellular interactions and immune responses without the need for direct peptide administration in all experimental setupsOT I Mouse. The sensitivity of peptides to degradation is also a consideration; peptide is more susceptible to random proteases made by splenocytes, which is an important factor for experimental design.

The OT-I peptide and the system it represents are integral to numerous research endeavors. They are responsible for the crosstalk and chemoattraction of immune cells and tumor cells, influencing the tumor microenvironment and immune surveillance. Furthermore, the broader field of peptide therapies offer targeted, low-risk treatments for a multitude of conditions, and the foundational understanding gained from studying peptides like OVA Peptide (257-264) directly contributes to this rapidly advancing area of medicine作者：LJ Young·2007·被引用次数：91—Proliferation ofOT-II T cells in the spleen was assessed 60 h later. The top profiles correspond to nonimmunized mice. (B) DCs purified from CpG-pretreated .... Advances in techniques like searching with a peptide sequence to find matching proteins in databases also highlight the pervasive importance of understanding peptide structures and their biological roles作者：PP Yachi·2006·被引用次数：201—TheOT-I TCR recognizes an ovalbumin-derivedpeptide(OVA) presented by H-2Kband a series of APLs with single amino acid substitutions. The activation .... The precise nature of the OT-I peptide recognition, particularly its interaction with class I (Kb)-restricted peptide epitope of OVA, ensures its continued prominence in immunological research and the development of novel therapeutic strategies.